Evaluation of SMN Protein, Transcript, and Copy Number in the Biomarkers for Spinal Muscular Atrophy (BforSMA) Clinical Study-Reference-Cited by-同舟云学术

Evaluation of SMN Protein, Transcript, and Copy Number in the Biomarkers for Spinal Muscular Atrophy (BforSMA) Clinical Study

Published:2012-04-27 Issue:4 Volume:7 Page:e33572
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Crawford Thomas O.,Paushkin Sergey V.,Kobayashi Dione T.,Forrest Suzanne J.,Joyce Cynthia L.,Finkel Richard S.,Kaufmann Petra,Swoboda Kathryn J.,Tiziano Danilo,Lomastro Rosa,Li Rebecca H.,Trachtenberg Felicia L.,Plasterer Thomas,Chen Karen S.,

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference55 articles.

1. Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy.;M Feldkotter;Am J Hum Genet,2002

2. Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2.;MD Mailman;Genet Med,2002

3. Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number.;PE McAndrew;Am J Hum Genet,1997

4. A novel association of the SMN protein with two major non-ribosomal nucleolar proteins and its implication in spinal muscular atrophy.;S Lefebvre;Hum Mol Genet,2002

5. Characterization of the Schizosaccharomyces pombe orthologue of the human survival motor neuron (SMN) protein.;N Owen;Hum Mol Genet,2000

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association among biomarkers, phenotypes, and motor milestones in Chinese patients with 5q spinal muscular atrophy types 1–3;Frontiers in Neurology;2024-09-02

2. Beyond Motor Neurons in Spinal Muscular Atrophy: A Focus on Neuromuscular Junction;International Journal of Molecular Sciences;2024-07-03

3. Preemptive dual therapy for children at risk for infantile‐onset spinal muscular atrophy;Annals of Clinical and Translational Neurology;2024-05-31

4. Changes in serum parameters during nusinersen treatment in children with spinal muscular atrophy;2024-04-29

5. Management and Therapeutic Strategies for Spinal Muscular Atrophy;Journal of Genetic Medicine and Gene Therapy;2024-03-29